BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18647414)

  • 1. Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.
    Rosada RS; de la Torre LG; Frantz FG; Trombone AP; Zárate-Bladés CR; Fonseca DM; Souza PR; Brandão IT; Masson AP; Soares EG; Ramos SG; Faccioli LH; Silva CL; Santana MH; Coelho-Castelo AA
    BMC Immunol; 2008 Jul; 9():38. PubMed ID: 18647414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 polarized response induced by intramuscular DNA-HSP65 immunization is preserved in experimental atherosclerosis.
    Fonseca DM; Bonato VL; Silva CL; Sartori A
    Braz J Med Biol Res; 2007 Nov; 40(11):1495-504. PubMed ID: 17934646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.
    Ruberti M; De Melo LK; Dos Santos SA; Brandao IT; Soares EG; Silva CL; Júnior JM
    J Drug Target; 2004 May; 12(4):195-203. PubMed ID: 15506168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
    Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice.
    Lima KM; Bonato VL; Faccioli LH; Brandão IT; dos Santos SA; Coelho-Castelo AA; Leão SC; Silva CL
    Vaccine; 2001 May; 19(25-26):3518-25. PubMed ID: 11348719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
    Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
    Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo.
    Lima KM; dos Santos SA; Santos RR; Brandão IT; Rodrigues JM; Silva CL
    Vaccine; 2003 Dec; 22(1):49-56. PubMed ID: 14604570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
    Okada M; Kita Y; Nakajima T; Hashimoto S; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC
    Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection.
    dos Santos SA; Zárate-Bladés CR; de Sá Galetti FC; Brandão IT; Masson AP; Soares EG; Araújo AP; Silva CL
    Hum Vaccin; 2010 Dec; 6(12):1047-53. PubMed ID: 21157178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis.
    Lorenzi JC; Trombone AP; Rocha CD; Almeida LP; Lousada RL; Malardo T; Fontoura IC; Rossetti RA; Gembre AF; Silva AM; Silva CL; Coelho-Castelo AA
    BMC Biotechnol; 2010 Oct; 10():77. PubMed ID: 20961459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.
    Ai W; Yue Y; Xiong S; Xu W
    Microbiol Immunol; 2013 Mar; 57(3):224-35. PubMed ID: 23489083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
    Lima KM; Santos SA; Lima VM; Coelho-Castelo AA; Rodrigues JM; Silva CL
    Gene Ther; 2003 Apr; 10(8):678-85. PubMed ID: 12692596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the immunogenicity between Hsp70 DNA vaccine and Hsp65 DNA vaccine in human Mycobacterium tuberculosis.
    Dai W; Huang H; Yuan Y; Hu J; Huangfu Y
    J Tongji Med Univ; 2001; 21(3):181-3. PubMed ID: 12539570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotrienes are not essential for the efficacy of a heterologous vaccine against Mycobacterium tuberculosis infection.
    Franco LH; Paula MO; Wowk PF; Fonseca DM; Sérgio CA; Fedatto PF; Gembre AF; Ramos SG; Silva CL; Medeiros AI; Faccioli LH; Bonato VL
    Braz J Med Biol Res; 2010 Jul; 43(7):645-50. PubMed ID: 20521013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65.
    Baek KM; Ko SY; Lee M; Lee JS; Kim JO; Ko HJ; Lee JW; Lee SH; Cho SN; Kang CY
    Vaccine; 2003 Sep; 21(25-26):3684-9. PubMed ID: 12922098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
    Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.